RSS  JOBS   SITE MAP 
 HOME 
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
 RESOURCE CENTER 
 NEWSLETTER 
 DIGITAL MAGAZINE 
  Saturday, February 4, 2012 SEARCH     
 
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND
 
NEW DEVELOPMENTS
NIH scientists find cause of rare immune disease
Investigators at the National Institutes of Health have identified a genetic mutation in three unrelated families that causes a rare immune disorder characterized by excessive and impaired immune function
Newly-developed stem cell therapy reverses diabetes
A newly-developed technology that uses stem cells from cord blood to re-educate diabetic patients own T cells was able to restart pancreatic function and reduce the need for insulin
TOP RESEARCH STORY
Roche's investigational treatment for asthma meets primary endpoint in ph II study
Roche announced that a phase II study of its investigational treatment lebrikizumab, a humanized monoclonal antibody designed to block interleukin-13 (IL-13) cytokine, met its primary endpoint
Tea can help blood vessels to relax: Report
Professor Jonathan Hodgson from the University of Western Australias School of Medicine and Pharmacology presented a critical overview on the potential benefits of tea regarding blood vessel health apart from it providing the body with hydration
TODAY'S NEWS
  Renaissance in genomics with next generation sequencing
  Starpharma releases animal data for dendrimer-docetaxel formulation
  PAREXEL collaborates with Korea's ASAN Medical
  CVS/pharmacy launches product for prescription text alerts
  FDA and industry agree on medical device user fees
  Prana comments on three scientific journal articles
 
Advertisement
 
Digital Mag

Issue: Jan 2012
Current Issue
View / Download
Top Story
Diabetes epidemic on the rise
 
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement

 

R & D
 
NIH scientists find cause of rare immune disease
Investigators at the National Institutes of Health have identified a genetic mutation in three unrelated families that causes a rare immune disorder characterized by excessive and impaired immune function
 
Newly-developed stem cell therapy reverses diabetes
A newly-developed technology that uses stem cells from cord blood to re-educate diabetic patients own T cells was able to restart pancreatic function and reduce the need for insulin
 
IBM contributes data to NIH to speed drug discovery and cancer research innovation
IBM announced it is contributing a massive database of chemical data extracted from millions of patents and scientific literature to the NIH. This contribution will allow researchers to more easily visualize relationships among chemical compounds
 
Taiwan researchers find possible markers of stem cell
A research team led by Dr. John Yu from Institute of Cellular and Organismic Biology, Taiwan has discovered that glycosphingolipids on the surface of cells change composition when human embryonic stem cells differentiate into specialized cells.
 
Singapore, China conduct first Asian genome-wide study on spine disease
Dr Liu Jianjun from Genome Institute of Singapore and Dr Gu Jieruo from Sun Yat-Sen University have identified new genes associated with the spine disease ankylosing spondylitis
 
Advinus GK-activator achieves early POC for diabetes
Advinus Therapeutics announced that it has successfully completed a 14-day POC (Proof of Concept) study in 60 Type II diabetic patients on its lead molecule, GKM-001, a glucokinase activator
 
Antibiotics for acne linked to sore throat
Oral antibiotics used to treat acne are linked to symptoms of sore throat, according to a study by researchers with the Perelman School of Medicine at the University of Pennsylvania
 
Genzyme announces successful phase III results for LEMTRADATM in multiple sclerosis
Sanofi and its subsidiary Genzyme report that the phase III CARE-MS ll trial met both of its co-primary endpoints
 
ShangPharma achieves milestone in drug candidate program for Biotica
ShangPharma Corporation through its wholly-owned Chinese subsidiary, Shanghai ChemPartner achieved a major milestone in the research and development of Sangamides
 
Clinuvel announces positive results of first phase II US study of SCENESSE
Clinuvel Pharmaceuticals announced positive results of its first US Phase II study of the novel photoprotective drug afamelanotide, known as SCENESSE
More
 
Advertisement











 
   
 
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Jobs at CyberMedia | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[DQ Channels]  [The DQweek]  [DARE]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black